-
1
-
-
72249087115
-
EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units
-
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, et al.; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-2329.
-
(2009)
JAMA
, vol.302
, pp. 2323-2329
-
-
Vincent, J.L.1
Rello, J.2
Marshall, J.3
Silva, E.4
Anzueto, A.5
Martin, C.D.6
Moreno, R.7
Lipman, J.8
Gomersall, C.9
Sakr, Y.10
-
2
-
-
0037451929
-
The epidemiology of sepsis in the United States from 1979 through 2000
-
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
-
(2003)
N Engl J Med
, vol.348
, pp. 1546-1554
-
-
Martin, G.S.1
Mannino, D.M.2
Eaton, S.3
Moss, M.4
-
3
-
-
53549090989
-
Secular trends in candidemiarelated hospitalization in the United States, 2000-2005
-
Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemiarelated hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol 2008;29:978-980.
-
(2008)
Infect Control Hosp Epidemiol
, vol.29
, pp. 978-980
-
-
Zilberberg, M.D.1
Shorr, A.F.2
Kollef, M.H.3
-
4
-
-
33646150918
-
Candidaemia in Europe: Epidemiology and resistance
-
Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006;27:359-366.
-
(2006)
Int J Antimicrob Agents
, vol.27
, pp. 359-366
-
-
Tortorano, A.M.1
Kibbler, C.2
Peman, J.3
Bernhardt, H.4
Klingspor, L.5
Grillot, R.6
-
5
-
-
78650859229
-
National surveillance of fungemia in Denmark (2004 to 2009)
-
Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Møller J, Nielsen L, et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 2011;49:325-334.
-
(2011)
J Clin Microbiol
, vol.49
, pp. 325-334
-
-
Arendrup, M.C.1
Bruun, B.2
Christensen, J.J.3
Fuursted, K.4
Johansen, H.K.5
Kjaeldgaard, P.6
Knudsen, J.D.7
Kristensen, L.8
Møller, J.9
Nielsen, L.10
-
6
-
-
33745313876
-
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
-
Garey KW, RegeM, PaiMP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006;43:25-31.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 25-31
-
-
Garey, K.W.1
Rege, M.2
Pai, M.P.3
Mingo, D.E.4
Suda, K.J.5
Turpin, R.S.6
Bearden, D.T.7
-
7
-
-
84867702517
-
ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures
-
ESCMID Fungal Infection Study Group
-
Cuenca-EstrellaM, Verweij PE, ArendrupMC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, et al.; ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012;18:9-18.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 9-18
-
-
Cuenca-Estrella, M.1
Verweij, P.E.2
Arendrup, M.C.3
Arikan-Akdagli, S.4
Bille, J.5
Donnelly, J.P.6
Jensen, H.E.7
Lass-Flörl, C.8
Richardson, M.D.9
Akova, M.10
-
8
-
-
67650486324
-
Cava Study Group. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
-
León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco- Navalproto MA, et al.; Cava Study Group. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009;37:1624-1633.
-
(2009)
Crit Care Med
, vol.37
, pp. 1624-1633
-
-
León, C.1
Ruiz-Santana, S.2
Saavedra, P.3
Galván, B.4
Blanco, A.5
Castro, C.6
Balasini, C.7
Utande-Vázquez, A.8
González, D.M.F.J.9
Blasco-, N.M.A.10
-
9
-
-
13444280095
-
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies
-
Prella M, Bille J, Pugnale M, Duvoisin B, Cavassini M, Calandra T, Marchetti O. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005;51:95-101.
-
(2005)
Diagn Microbiol Infect Dis
, vol.51
, pp. 95-101
-
-
Prella, M.1
Bille, J.2
Pugnale, M.3
Duvoisin, B.4
Cavassini, M.5
Calandra, T.6
Marchetti, O.7
-
11
-
-
84887296457
-
Fungal Infection Network of Switzerland (FUNGINOS). Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasiss
-
Tissot F, Lamoth F, Hauser PM, Orasch C, Flückiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, et al.; Fungal Infection Network of Switzerland (FUNGINOS). Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 2013;188:1100-1109.
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 1100-1109
-
-
Tissot, F.1
Lamoth, F.2
Hauser, P.M.3
Orasch, C.4
Flückiger, U.5
Siegemund, M.6
Zimmerli, S.7
Calandra, T.8
Bille, J.9
Eggimann, P.10
-
12
-
-
0035668391
-
Fungal beta(1, 3)-D-glucan synthesis
-
Douglas CM. Fungal beta(1, 3)-D-glucan synthesis. Med Mycol 2001;39: 55-66.
-
(2001)
Med Mycol
, vol.39
, pp. 55-66
-
-
Douglas, C.M.1
-
13
-
-
79953766802
-
B-D-glucan assay for the diagnosis of invasive fungal infections: A meta-analysis
-
Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, FalagasME. b-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011;52:750-770.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 750-770
-
-
Karageorgopoulos, D.E.1
Vouloumanou, E.K.2
Ntziora, F.3
Michalopoulos, A.4
Rafailidis, P.I.5
Falagas, M.E.6
-
14
-
-
75949113583
-
PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial
-
Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, et al.; PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463-474.
-
(2010)
Lancet
, vol.375
, pp. 463-474
-
-
Bouadma, L.1
Luyt, C.E.2
Tubach, F.3
Cracco, C.4
Alvarez, A.5
Schwebel, C.6
Schortgen, F.7
Lasocki, S.8
Veber, B.9
Dehoux, M.10
|